MYO Executive Compensation
* In USD (Original Currency)
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
---|---|---|---|---|---|---|---|---|
2023-04-28 | 2021 | Harry Kovelman, Chief Medical Officer | 220,508 | 0 | 102,171 | 124,453 | 0 | 447,132 |
2023-04-28 | 2022 | Harry Kovelman, Chief Medical Officer | 234,008 | 0 | 62,440 | 29,503 | 14,073 | 340,024 |
2023-04-28 | 2021 | David A. Henry Chief Financial Officer | 217,427 | 0 | 249,198 | 150,965 | 620 | 618,210 |
2023-04-28 | 2022 | David A. Henry Chief Financial Officer | 224,056 | 0 | 92,545 | 34,222 | 14,819 | 365,642 |
2023-04-28 | 2021 | Paul R. Gudonis, Chief Executive Officer | 268,154 | 0 | 498,395 | 191,023 | 0 | 957,572 |
2023-04-28 | 2022 | Paul R. Gudonis, Chief Executive Officer | 300,000 | 0 | 167,250 | 45,000 | 13,793 | 526,043 |
2022-04-29 | 2021 | Paul R. Gudonis, Chief Executive Officer | 268,154 | 0 | 498,395 | 191,023 | 0 | 957,572 |
2022-04-29 | 2020 | Paul R. Gudonis, Chief Executive Officer | 240,000 | 24,000 | 127,400 | 174,510 | 1,200 | 567,110 |
2022-04-29 | 2021 | David A. Henry Chief Financial Officer | 217,427 | 0 | 249,198 | 150,965 | 620 | 618,210 |
2022-04-29 | 2020 | David A. Henry Chief Financial Officer | 214,994 | 0 | 91,000 | 159,154 | 1,200 | 466,348 |
2022-04-29 | 2021 | Micah J. Mitchell, Chief Commercial Officer | 182,533 | 0 | 142,043 | 134,858 | 0 | 459,434 |
2022-04-29 | 2020 | Micah J. Mitchell, Chief Commercial Officer | 179,998 | 0 | 63,700 | 140,616 | 0 | 384,314 |
2021-04-28 | 2020 | Paul R. Gudonis, Chief Executive Officer | 240,000 | 24,000 | 127,400 | 174,510 | 1,200 | 567,110 |
2021-04-28 | 2019 | Micah J. Mitchell, Chief Commercial Officer | 179,998 | 0 | 35,992 | 70,653 | 0 | 286,643 |
2021-04-28 | 2020 | Micah J. Mitchell, Chief Commercial Officer | 179,998 | 0 | 63,700 | 140,616 | 0 | 384,314 |
2021-04-28 | 2020 | David A. Henry | 214,994 | 0 | 91,000 | 159,154 | 1,200 | 466,348 |
2021-04-28 | 2019 | Paul R. Gudonis, Chief Executive Officer | 240,000 | 0 | 133,800 | 65,506 | 4,750 | 444,056 |
2020-04-28 | 2019 | Paul R. Gudonis, Chief Executive Officer | 240,000 | 0 | 133,800 | 65,506 | 4,750 | 444,056 |
2020-04-28 | 2018 | Paul R. Gudonis, Chief Executive Officer | 240,000 | 0 | 0 | 126,000 | 4,200 | 537,592 |
2020-04-28 | 2019 | David A. Henry | 181,918 | 25,000 | 26,800 | 63,261 | 4,000 | 340,617 |
2020-04-28 | 2019 | Jonathan Naft, Vice President | 200,000 | 0 | 44,990 | 60,394 | 0 | 305,384 |
2020-04-28 | 2018 | Jonathan Naft, Vice President | 200,000 | 0 | 0 | 115,000 | 0 | 356,848 |
2019-04-26 | 2017 | Jonathan Naft, General Manager—O&P Division | 153,778 | 0 | 0 | 91,023 | 0 | 244,801 |
2019-04-26 | 2018 | Jonathan Naft, General Manager—O&P Division | 200,000 | 0 | 0 | 115,000 | 0 | 356,848 |
2019-04-26 | 2017 | Ralph A. Goldwasser former Chief Financial Officer | 100,000 | 91,023 | 67,500 | 0 | 0 | 269,813 |
2019-04-26 | 2018 | Ralph A. Goldwasser former Chief Financial Officer | 200,000 | 0 | 0 | 115,000 | 0 | 398,696 |
2019-04-26 | 2017 | Paul Gudonis, Chief Executive Officer | 186,333 | 0 | 0 | 109,227 | 3,600 | 299,160 |
2019-04-26 | 2018 | Paul Gudonis, Chief Executive Officer | 240,000 | 0 | 0 | 126,000 | 4,200 | 537,592 |
2018-04-26 | 2016 | Davie Mendelsohn, Vice President – Sales & Clinical Services | 120,000 | 0 | 0 | 0 | 0 | 123,165 |
2018-04-26 | 2017 | Davie Mendelsohn, Vice President – Sales & Clinical Services | 131,056 | 74,818 | 0 | 0 | 0 | 205,874 |
2018-04-26 | 2016 | Jonathan Naft, General Manager – O&P Division | 100,000 | 0 | 0 | 65,950 | 0 | 169,115 |
2018-04-26 | 2017 | Jonathan Naft, General Manager – O&P Division | 153,778 | 91,023 | 0 | 0 | 0 | 244,801 |
2018-04-26 | 2016 | Paul Gudonis, Chief Executive Officer | 48,000 | 0 | 0 | 0 | 3,600 | 56,155 |
2018-04-26 | 2017 | Paul Gudonis, Chief Executive Officer | 186,333 | 109,227 | 0 | 0 | 3,600 | 299,160 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.